Advances of Candida albicans biofilm construction in vitro and in vivo

Abstract

Abstract:

The chronic and refractory candidal infections caused by Candida albicans have close relations with its biofilms formation. Many biological characteristics of biofilm are different from those of planktonic counterparts. Proper constructions of biofilm model are critical to the researches of the mechanism of biofilm formation and medicinal intervention. In this paper, the authors make a comprehensive review of in vitro and in vivo biofilm constructions of Candida albicans at home and abroad according to their studies.

Key words: Candida albicans, biofilm, in vivo model, in vitro model

CLC Number:

R 379.4

SHAO Jing, WANG Chang-zhong, WANG Tian-ming, CHENG Hui-juan. Advances of Candida albicans biofilm construction in vitro and in vivo[J]. Chinese Journal of Mycology, 2012, 7(6): 380-384.

References

[1] Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care
[J]. BMC Infect Dis,2006,6:21.

[2] Tobudic S,Kratzer C,Lassnigg A,et al. Antifungal susceptibility of Candida albicans in biofilms
[J]. Mycoses,2012, 55(3): 199-204.

[3] Davies D. Understanding biofilm resistance to antibacterial agents
[J]. Nat Rev Drug Discov, 2003, 2(2): 114-122.

[4] Ramage G, Vande Walle K, Wickes BL, et al.Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
[J]. Antimicrob Agents Chemother,2001, 45(9): 2475-2479.

[5] Nweze EI, Ghannoum A, Chandra J, et al. Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms
[J]. J Antimicrob Chemother, 2012, 67(1): 149-153.

[6] Lafleur MD, Lucumi E, Napper AD, et al. Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms
[J]. J Antimicrob Chemother,2011, 66(4): 820-826.

[7] 赵今,李继遥,朱昞,等. 口腔多菌种生物膜对防龋中药敏感性的实验研究
[J].华西口腔医学杂志,2006,24(6):546-550.

[8] Ceri H, Olson ME, Stremick C, et al. The Calgary Biofilm Device: Measurement of antimicrobial sensitivity of bacterial biofilms
[J]. J Clin Microbiol, 1999, 37: 1771-1776.

[9] Harrison JJ, Turner RJ, Ceri H. High-throughput metal susceptibility testing of microbial biofilms
[J]. BMC Microbiol, 2005, 5: 53-64.

[10] Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance
[J]. J Med Microbiol,2006, 55(Pt 8): 999-1008.

[11] De Prijck K, De Smet N, Coenye T, et al. Prevention of Candida albicans biofilm formation by covalently bound dimethylaminoethylmethacrylate and polyethylenimine
[J]. Mycopathologia,2010, 170(4): 213-221.

[12] Nailis H, Vandenbroucke R, Tilleman K, et al. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions
[J]. Mycopathologia, 2009, 167(1): 9-17.

[13] Frade JP, Arthington-Skaggs BA. Effect of serum and surface characteristics on Candida albicans biofilm formation
[J]. Mycoses,2011, 54(4): e154-e162.

[14] Li F, Svarovsky MJ, Karlsson AJ,et al. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo
[J]. Eukaryot Cell,2007, 6(6): 931-939.

[15] Samaranayake YH, Ye J, Yau JY, et al.In vitro method to study antifungal perfusion in Candida biofilms
[J]. J Clin Microbiol, 2005, 43(2): 818-825.

[16] Imamura Y, Chandra J, Mukherjee PK, et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions
[J]. Antimicrob Agents Chemother,2008, 52(1): 171-182.

[17] Chandra J, Mukherjee P K, Ghannoum M A.In vitro growth and analysis of Candida biofilms. Nature Protocols,2008, 3: 1909-1924.

[18] Nett J, Lincoln L, Marchillo K,et al. Beta-1,3 glucan as a test for central venous catheter biofilm infection
[J]. J Infect Dis,2007, 195(11): 1705-1712.

[19] Toulet D, Debarre C, Imbert C. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?
[J]. J Antimicrob Chemother,2012, 67(2): 430-432.

[20] Cateau E, Berjeaud JM, Imbert C. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone
[J]. Int J Antimicrob Agents,2011, 37(4): 380-384.

[21] Richard ML, Nobile CJ, Bruno VM, et al.Candida albicans biofilm-defective mutants. Eukaryot Cell,2005, 4(8): 1493-1502.

[22] Negri M, Martins M, Henriques M, et al. Examination of Potential Virulence Factors of Candida tropicalis Clinical Isolates From Hospitalized Patients
[J]. Mycopathologia,2010, 169(3): 175-182.

[23] Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, et al. Characterization of mucosal Candida albicans biofilms
[J]. PLoS ONE,2009, 4(11): e7967.

[24] Nett JE, Marchillo K, Spiegel CA, et al. Development and validation of an in vivo Candida albicans biofilm denture model
[J]. Infect Immun,2010, 78(9): 3650-3659.

[25] Paiva LCF, Vidigal PG, Donatti L, et al. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics
[J]. Micron,2012, 43(2-3): 497-502.

[26] Harriott MM, Lilly EA, Rodriguez TE, et al.Candida albicans forms biofilms on the vaginal mucosa
[J]. Microbiology,2010, 156(Pt 12):3635-3644.

[27] Soňa Kucharíková, Hélène Tournu, Michelle Holtappels,et al.In vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated Candidiasis
[J]. Antimicrob Agents Chemother,2010, 54(10): 4474-4475.

[28] Markéta Ricicová, Soňa Kucharíková, Hélène Tournu, et al.Candida albicans biofilm formation in a new in vivo rat model
[J]. Microbiology, 2010, 156(3): 909-919.

[29] 阳隽,张天托,朱家馨. 呼吸道白念珠菌分离株表型差异的机制
[J]. 南方医科大学学报,2012, 32(9): 1307-1311.